NEW YORK (GenomeWeb News) – Microbial biomarker technologies developer Second Genome has undertaken an initiative with American Gut, a multi-partner effort to characterize the microbial diversity of the gut, to study the possible roles the human microbiome may play in type 2 diabetes.

Under the initiative, Second Genome made a donation to American Gut of an undisclosed amount to fund specimen collection for participants who have type 2 diabetes, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.